SEC Info - Boxer Capital, LLC, et al. - ‘SC 13D/A’ on 8/16/23 re: Mirati Therapeutics, Inc.

Boxer Capital, LLC, et al. – ‘SC 13D/A’ on 8/16/23 re: Mirati Therapeutics, Inc. – ‘EX-1’

On: Wednesday, 8/16/23, at 4:28pm ET · Accession #: 895345-23-502 · File #: 5-87670

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/16/23 Boxer Capital, LLC SC 13D/A 2:271K Mirati Therapeutics, Inc. Fried Fr… Jacobson/NY/FA Aaron I. Davis Boxer Asset Management Inc. Braslyn Ltd. Christopher Fuglesang Joe Lewis Lockend Five, LLC Mva Investors, LLC Shehan B. Dissanayake

Document/Exhibit Description Pages Size 1: SC 13D/A Amendment to Statement of Acquisition of HTML 250K Beneficial Ownership by an "Active" Investor 2: EX-1 Underwriting Agreement or Conflict Minerals Report HTML 20K

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to Common Stock, $0.001 par value per share, of Mirati Therapeutics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: August 15, 2023

	BOXER CAPITAL, LLC

	By:	/s/ *Aaron I. Davis*
	Name:	Aaron I. Davis
	Title:	Chief Executive Officer


	BOXER ASSET MANAGEMENT INC.

	By:	/s/ *Paul Higgs*
	Name:	Paul Higgs
	Title:	Director


	BRASLYN LTD.

	By:	/s/ *Jason Callender*
	Name:	Jason Callender
	Title:	Director


	MVA INVESTORS, LLC

	By:	/s/ *Aaron I. Davis*
	Name:	Aaron I. Davis
	Title:	Authorized Signatory


	LOCKEND FIVE, LLC

	By:	/s/ *Greg Miller*
	Name:	Greg Miller
	Title:	Manager


	JOSEPH C. LEWIS

	By:	/s/ *Joseph C. Lewis*
		Joseph C. Lewis, Individually


	AARON I. DAVIS

	By:	/s/ *Aaron I. Davis*
		Aaron I. Davis, Individually

	SHEHAN B. DISSANAYAKE

	By:	/s/ *Shehan B. Dissanayake*
		Shehan B. Dissanayake, Individually


	CHRISTOPHER FUGLESANG

	By:	/s/ *Christopher Fuglesang*
		Christopher Fuglesang, Individually

This ‘SC 13D/A’ Filing

Date

Other Filings

Filed on:

8/16/23

8/15/23

List all Filings

Boxer Capital, LLC, et al. – ‘SC 13D/A’ on 8/16/23 re: Mirati Therapeutics, Inc. – ‘EX-1’

On: Wednesday, 8/16/23, at 4:28pm ET · Accession #: 895345-23-502 · File #: 5-87670

Previous ‘SC 13D’: ‘SC 13D/A’ on 5/25/23 · Next: ‘SC 13D/A’ on 10/12/23 · Latest: ‘SC 13D/A’ on 2/8/24

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

‘EX-1’ — Underwriting Agreement or Conflict Minerals Report

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Boxer Capital, LLC, et al. – ‘SC 13D/A’ on 8/16/23 re: Mirati Therapeutics, Inc. – ‘EX-1’

On: Wednesday, 8/16/23, at 4:28pm ET · Accession #: 895345-23-502 · File #: 5-87670

Previous ‘SC 13D’: ‘SC 13D/A’ on 5/25/23 · Next: ‘SC 13D/A’ on 10/12/23 · Latest: ‘SC 13D/A’ on 2/8/24

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68Filing Table of Contents

‘EX-1’ — Underwriting Agreement or Conflict Minerals Report

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents